ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.400
-0.050 (-1.45%)
At close: May 29, 2026, 4:00 PM EDT
3.400
0.00 (0.00%)
Pre-market: Jun 1, 2026, 4:00 AM EDT
ADC Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, ADC Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $8.20. The average 1-year stock price forecast is 141.18% higher than the current stock price, while the lowest is $6.00 (+76.47%) and the highest is $10 (+194.12%).
Price Target: $8.20 (+141.18%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ADC Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $6 | Buy | Maintains | $6 | +76.47% | May 8, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $10 | Buy | Maintains | $10 | +194.12% | May 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +135.29% | May 5, 2026 |
Financial Forecast
Revenue This Year
83.09M
from 81.36M
Increased by 2.12%
Revenue Next Year
139.63M
from 83.09M
Increased by 68.06%
EPS This Year
-0.87
from -1.12
EPS Next Year
-0.63
from -0.87
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 92.5M | 156.8M | ||||
| Avg | 83.1M | 139.6M | ||||
| Low | 71.9M | 115.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 13.7% | 88.8% | ||||
| Avg | 2.1% | 68.1% | ||||
| Low | -11.6% | 39.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.82 | -0.46 | |
| Avg | -0.87 | -0.63 | |
| Low | -0.88 | -0.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.